Suvorexant
| CAS No. | 1030377-33-3 |
|---|---|
| MDL No. | MFCD22377755 |
| MF | C23H23ClN6O2 |
| MW | 450.90 |
| InChI Key | JYTNQNCOQXFQPK-MRXNPFEDSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Suvorexant is an aromatic amide formed by the formal condensation of the carboxy group of 5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid with the secondary amino group of 5-chloro-2-[(5R)-5-methyl-1,4-diazepan-1-yl]-1,3-benzoxazole. It is an orexin receptor antagonist used for insomnia management. It acts as a central nervous system depressant and is classified as a 1,3-benzoxazole, triazole, diazepine, aromatic amide, and organochlorine compound.
| CAS No. | 1030377-33-3 |
|---|---|
| Product Name | Suvorexant |
Biological Targets
HCRTR2·HCRTR1
Associated Conditions
alcohol dependence·nicotine dependence·delirium·Alzheimer disease·sleep apnea·
* The information provided here is compiled from public sources and is for reference only.